Zubair Khalid

Virologist/Molecular Biologist | Veterinarian | Bioinformatician

Conventional & Molecular Virology • Vaccine Development • Computational Biology

Dr. Zubair Khalid is a veterinarian and virologist specializing in conventional and molecular virology, vaccine development, and computational biology. Dedicated to advancing animal health through innovative research and multi-omics approaches.

Dr. Zubair Khalid - Veterinarian, Virologist, and Vaccine Development Researcher specializing in Computational Biology, Multi-omics, Animal Health, and Infectious Disease Research

Section: Livestock Bacteria

Trueperella pyogenes: Taxonomy, Virulence, Pathogenesis, Antimicrobial Resistance, and Molecular Epidemiology

Microscopy-style illustration of trueperella pyogenes bacteria showing cell morphology
Illustration generated with AI for editorial purposes.

Introduction

Trueperella pyogenes is a Gram-positive, facultatively anaerobic, non‑spore‑forming, pleomorphic rod that belongs to the family Actinomycetaceae [26]. The organism is a commensal of the skin and mucous membranes of the upper respiratory, gastrointestinal, and urogenital tracts of many domestic and wild animal species [26, 1]. Under conditions of immunosuppression, tissue damage, or co‑infection with other pathogens, T. pyogenes acts as an opportunistic pathogen and causes suppurative, often chronic, infections such as mastitis, endometritis, pneumonia, liver abscesses, and omphalitis [26, 1, 2]. In cattle, it is a principal agent of Trueperella (Arcanobacterium) pyogenes infections in cattle: summer mastitis and liver abscess (see [link]) and pyometra (see [link]) [3, 27]. Economic losses arise from reduced milk yield, fertility impairment, treatment costs, and carcass condemnation [26, 2]. The bacterium is also isolated from sheep, goats, pigs, European bison, forest musk deer, and, rarely, humans [1, 4, 5, 33].

Taxonomy

T. pyogenes was originally classified as Corynebacterium pyogenes and later transferred to the genus Arcanobacterium; based on 16S rRNA gene sequencing and chemotaxonomic data, it was reassigned to the novel genus Trueperella [26]. The species is closely related to Trueperella abortisuis and Trueperella bialowiezensis [26]. The cell wall contains meso‑diaminopimelic acid and a type A1γ peptidoglycan, and the major fatty acids are C16:0 and C18:1ω9c [26].

Virulence Factors

T. pyogenes possesses a repertoire of virulence determinants that mediate adhesion, cytotoxicity, tissue degradation, and immune evasion. The major virulence factor is pyolysin (PLO), a cholesterol‑dependent cytolysin (CDC) that forms transmembrane pores in host cell membranes [26, 6, 30]. PLO is responsible for the β‑hemolysis observed on blood agar and triggers pyroptosis and IL‑1β release in macrophages via the potassium‑dependent NLRP3/caspase‑1/gasdermin D pathway [30, 6].

Other important virulence factors include fimbriae (FimA, FimC, FimE, FimG), neuraminidases (NanH, NanP), and the collagen‑binding protein CbpA [26, 1, 7, 8]. Fimbriae facilitate adherence to host epithelial cells, while neuraminidases remove sialic acid residues from host glycoproteins, exposing receptors for bacterial adhesion [26, 1]. CbpA mediates binding to collagen‑rich tissues, which is thought to be important in the establishment of abscesses in organs such as the liver and spleen [26, 8]. The prevalence of these genes varies among isolates and host species; for example, plo and fimA are nearly universal, whereas fimG and cbpA are less frequent [7, 8, 23]. A summary of commonly reported virulence‑associated genes is provided in Table 1.

Table 1. Frequency of virulence‑associated genes in T. pyogenes isolates from different hosts (representative data from selected studies).

Gene Product Cattle (%) Goats (%) Sheep (%)
plo Pyolysin 100 100 100
fimA Fimbrillin A 100 96 93
fimC Fimbrial subunit C 89 84 59
fimE Fimbrial subunit E 87 82
fimG Fimbrial subunit G 7 0
nanH Neuraminidase H 40 100 64
nanP Neuraminidase P 76 100 72
cbpA Collagen‑binding protein A 36 68 67
Data compiled from [8] (cattle), [7] (goats), and [5] (sheep). – = not determined.

In addition to proteinaceous factors, T. pyogenes produces membrane vesicles (MVs) that carry virulence‑associated cargo. MVs isolated from T. pyogenes activate the NLRP3 inflammasome and MyD88/NF‑κB pathways in bovine endometrial epithelial cells (BEECs), leading to time‑ and dose‑dependent secretion of IL‑1β, IL‑6, IL‑18, and TNF‑α [9]. MVs induce necrosis‑like membrane disruption at high concentrations but apoptosis and pyroptosis at moderate levels [9].

Pathogenesis and Host Interactions

The infection process begins with adhesion to host epithelial cells or extracellular matrix components, mediated by fimbriae and CbpA [26, 1]. Viral co‑infections can enhance colonization; for example, bovine respiratory syncytial virus (BRSV) infection significantly increases the attachment of T. pyogenes to host cells, and this effect is mediated by the BRSV G protein [10]. Within the bovine respiratory disease complex (BRDC), T. pyogenes is frequently isolated together with Mycoplasma bovis; co‑culture of both organisms results in enhanced biofilm formation and increased resistance to antimicrobial agents [11]. In the uterus, T. pyogenes is a common cause of clinical endometritis, and its presence is associated with delayed conception and reduced fertility [3, 12]. The bacterium can also invade deeper tissues, leading to abscess formation in the liver, spleen, kidney, and lungs [2, 13].

Systemic dissemination is facilitated by pyolysin, which not only causes direct cytolysis but also triggers a strong inflammatory response. In murine macrophages, both inactivated whole cells and purified PLO upregulate IL‑1β gene transcription in an NF‑κB‑dependent manner [6]. However, only PLO (not heat‑killed bacteria) promotes IL‑1β maturation through caspase‑1 activation, which requires K+ efflux and NLRP3 [6, 30]. These findings underscore the central role of PLO in eliciting pyroptosis and the release of pro‑inflammatory cytokines.

Host Range and Clinical Syndromes

T. pyogenes infects a wide spectrum of mammalian hosts. In cattle, it is associated with summer mastitis (a severe, gangrenous form of mastitis occurring mainly in non‑lactating heifers), liver abscesses (often in feedlot cattle), metritis, endometritis, pneumonia, and omphalitis [27, 13, 2]. For detailed descriptions of bovine syndromes, see the dedicated articles on [Trueperella pyogenes infections in cattle: summer mastitis and liver abscess] and [Trueperella pyogenes infections in cattle: pyometra, liver abscesses, and summer mastitis]. In sheep and goats, the organism causes abscesses in various organs, mastitis, and granulomatous omentitis (often in co‑infection with Corynebacterium pseudotuberculosis) [14, 7, 5]. T. pyogenes is also a cause of orchitis in rams (see [Arcanobacterium pyogenes (Trueperella) infection in sheep: abscesses and orchitis]) [26]. In pigs, it is involved in pneumonia, polyarthritis, and abscesses [4, 25]. The bacterium has been isolated from European bison, forest musk deer, Korean native cattle, and companion animals such as cats, horses, and rabbits [15, 16, 13]. In humans, T. pyogenes rarely causes infections, but cases of endocarditis, prosthetic joint infection, and rhinosinusitis with cavernous sinus thrombosis have been reported, often in immunocompromised individuals or those with livestock contact [33, 24, 4].

Antimicrobial Resistance

Antimicrobial resistance (AMR) in T. pyogenes is an emerging concern. Phenotypic resistance profiles vary by geographic region and host species. High resistance rates to streptomycin (up to 88.9%) and tetracycline (up to 64.4%) have been reported in bovine mastitis isolates in China [8]. In a study of cattle and pig isolates from Japan, all tetracycline‑resistant strains carried tet(W), tet(M), tet(33), tet(K), or tet(L), and the distribution of these genes differed significantly between cattle and pigs, suggesting limited cross‑transmission [25]. Macrolide resistance is mediated by erm(X), erm(B), and erm(56) [8, 25, 23]. Aminoglycoside resistance is conferred by a variety of genes, including aadA9, aadA1, strA‑strB, and aph(3′)‑IIIa [23, 3, 8]. Importantly, class 1 integrons have been detected in bovine isolates, carrying gene cassettes such as aadA1‑aadB and aadA24‑dfrA1, which may facilitate the spread of resistance determinants [8, 25]. Multidrug resistance (MDR), defined as resistance to three or more antimicrobial classes, is observed in 15% to 43% of isolates [5, 17]. Despite this, β‑lactam antibiotics (penicillin, amoxicillin, ceftiofur) remain highly effective, with MIC90 values ≤ 2 μg/mL [12, 13]. Tetracyclines, gentamicin, and sulfamethoxazole/trimethoprim exhibit high MIC90 values, limiting their clinical utility [12]. Table 2 summarizes representative MIC90 values.

Table 2. MIC90 (μg/mL) of selected antimicrobials against T. pyogenes from bovine clinical endometritis [12].

Antimicrobial MIC90 (μg/mL)
Amoxicillin ≤2
Ceftiofur ≤2
Tylosin ≤2
Tulathromycin 4
Florfenicol 8
Oxytetracycline 16
Enrofloxacin 16
Gentamicin 32
Sulfamethoxazole/trimethoprim >32

Genotypic characterization using whole‑genome sequencing (WGS) has revealed that resistance genes are often located on genetic elements integrated into the chromosome [4]. For instance, aadA9 and sul1 are frequently found together, and tet(W) is commonly present [4, 8]. The presence of resistance genes typically associated with Gram‑negative bacteria (e.g., aadA variants) suggests horizontal gene transfer events [4].

Molecular Epidemiology and Typing

Several molecular typing methods have been applied to study the population structure of T. pyogenes. Random amplified polymorphic DNA (RAPD)‑PCR provides high discriminatory power and has been optimized for this species [34, 7]. RAPD analysis of caprine isolates showed 19 distinct profiles among 51 isolates, with some profiles shared among animals within the same herd or even across different herds [7]. A multilocus sequence typing (MLST) scheme based on seven housekeeping genes (adk, gyrB, leuA, metG, recA, tpi, tuf) has recently been developed [18]. Among 114 isolates, 91 sequence types (STs) were identified, grouped into six clonal complexes. Some correlation between STs and host species was observed, but no geographic clustering was apparent [18]. Whole‑genome sequencing and core‑genome MLST (cgMLST) have further refined phylogenetic relationships; cattle and human isolates cluster together, suggesting a zoonotic link [4, 15].

The diagnostic workflow for T. pyogenes infections typically proceeds as outlined in Figure 1.

flowchart TD
    A[Clinical specimen <br/> (pus, swab, milk, tissue)], > B[Gram stain & culture <br/> (blood agar, 5% CO2, 24-48h)]
    B, > C{Small, β-hemolytic <br/> colonies?}
    C, >|Yes| D[Catalase negative <br/> CAMP inhibition positive]
    D, > E[Confirm by <br/> MALDI-TOF MS or PCR <br/> (16S rRNA, plo gene)]
    C, >|No| F[Perform additional <br/> biochemical tests or <br/> 16S sequencing]
    E, > G[Antimicrobial <br/> susceptibility testing <br/> (disk diffusion or MIC)]
    G, > H[Report results <br/> & guide therapy]

Figure 1. Diagnostic algorithm for the identification of Trueperella pyogenes.

Biofilm Formation

Many T. pyogenes isolates are capable of forming biofilms in vitro. Biofilm formation is strain‑dependent; in a study of caprine isolates, 72.5% were classified as strong biofilm formers [7]. Biofilm‑associated genes include luxS, plo, rbsB, and lsrB [35]. Luteolin, a natural flavonoid, inhibits T. pyogenes biofilm at sub‑inhibitory concentrations, reducing the expression of these genes and dispersing pre‑formed biofilm [35]. In a rat endometritis model, luteolin alleviated uterine inflammation and reduced bacterial load [35]. Furthermore, luteolin acts as an inhibitor of the MsrA efflux pump, increasing the susceptibility of T. pyogenes to macrolides [32]. The serine/threonine protein kinase PknB and serine/threonine phosphatase STP are also targeted by luteolin, with molecular docking and interaction assays confirming binding affinities in the micromolar range [19].

Immune Response and Inflammation

The inflammatory response to T. pyogenes is driven primarily by PLO and MVs. In bovine endometrial epithelial cells, T. pyogenes and its MVs activate the MyD88/NF‑κB pathway, leading to the production of IL‑1β, IL‑6, TNF‑α, and IL‑18 [9]. PLO induces potassium efflux, which triggers the NLRP3 inflammasome, caspase‑1 activation, and cleavage of gasdermin D, culminating in pyroptosis and IL‑1β release [30, 6]. In murine macrophages, both inactivated T. pyogenes cells and PLO upregulate IL‑1β transcription via NF‑κB, but only PLO is able to stimulate IL‑1β maturation [6]. These mechanisms explain the intense purulent inflammation seen in T. pyogenes infections.

Vaccination and Alternative Therapies

Given the increasing prevalence of AMR, vaccine development is a priority. Several subunit vaccine candidates have been evaluated in mouse models. A recombinant version of pyolysin lacking domain 4 (rPLO D123), combined with serine metalloprotease (rSMP) and anchor M domain‑containing protein (rAMD), induced high antibody titers and provided partial protection against challenge [20]. Vaccines containing rSMP alone or in combination gave the best protection, with reduced tissue damage and higher survival rates [20]. Immunoinformatic approaches have also been used to design multi‑epitope vaccines based on CbpA, fimbriae, and PLO [21].

Phytochemicals offer alternative or adjunctive therapies. Cinnamon essential oil shows strong bactericidal activity against T. pyogenes isolates from bovine endometritis, with MIC values lower than those of oregano or thyme oils [31]. Furazolidone, a nitrofuran, reduces the virulence of T. pyogenes and Pseudomonas aeruginosa in a co‑infection mouse model of abscess disease, suppressing quorum‑sensing genes and core virulence regulators [22]. Bromhexine hydrochloride also exhibits antimicrobial activity against T. pyogenes in vitro [29].

Diagnostic Approaches

Definitive identification of T. pyogenes relies on culture, biochemical characterization (catalase‑negative, CAMP inhibition), and confirmatory molecular methods such as PCR targeting the plo gene or 16S rRNA gene sequencing [16, 28]. Matrix‑assisted laser desorption/ionization time‑of‑flight mass spectrometry (MALDI‑TOF MS) provides rapid and accurate identification at the species level [27]. For epidemiological typing, RAPD‑PCR [34] and MLST [18] are the methods of choice. Genotypic antimicrobial susceptibility testing using whole‑genome sequencing is increasingly used to predict resistance profiles [4, 15].

Frequently Asked Questions

What is the primary virulence factor of Trueperella pyogenes?

Pyolysin (PLO), a cholesterol‑dependent cytolysin, is the major virulence factor responsible for hemolysis, pore formation, pyroptosis, and IL‑1β release [26, 30, 6].

Which animal species are most commonly affected by T. pyogenes?

Cattle, sheep, goats, and pigs are the most frequently affected domestic species; the bacterium also infects wildlife such as European bison and forest musk deer [1, 4, 5, 15].

Is Trueperella pyogenes zoonotic?

Yes, but human infections are rare. Most reported cases involve immunocompromised individuals or those with occupational exposure to livestock [33, 24, 4].

What antimicrobials are effective against T. pyogenes?

β‑lactams (penicillin, amoxicillin, ceftiofur) and macrolides (tylosin) show excellent in vitro activity. Tetracyclines and sulfonamides have high MIC90 values and are less reliable [12, 13].

How is T. pyogenes diagnosed in the laboratory?

Positive diagnosis is made by culturing the organism on blood agar (β‑hemolytic, small colonies), followed by confirmation with MALDI‑TOF MS or PCR detection of the plo gene [16, 27].

Does T. pyogenes form biofilms?

Yes, many isolates are strong biofilm producers, and biofilm formation is enhanced by co‑culture with Mycoplasma bovis [11, 7]. The biofilm‑associated gene luxS is commonly present [35].

Can T. pyogenes infections be prevented by vaccination?

Experimental subunit vaccines containing pyolysin, serine metalloprotease, and anchor M domain proteins have shown promise in mouse models, but no commercial vaccine is yet available [20, 21].

References

[1] Wen X, Cheng J, Liu M. Virulence factors and therapeutic methods of Trueperella pyogenes: A review. Virulence. 2025. https://www.semanticscholar.org/paper/938bc92fa0e8f3a429695bf2fad71e45c1bc29e4

[2] Hamedi M, Esmaeili H, Ashrafi Tamai I, et al. Trueperella pyogenes; a Cause of Spleen Multi Abscesses in Cattle. J Med Bacteriol. 2025. https://www.semanticscholar.org/paper/b05f91f365dec4eba792320274dd9588ee306c38

[3] Liu N, Shan Q, Wu X, et al. Phenotypic Characteristics, Antimicrobial Susceptibility and Virulence Genotype Features of Trueperella pyogenes Associated with Endometritis of Dairy Cows. Int J Mol Sci. 2024. https://www.semanticscholar.org/paper/2eedc36509e561421dc4ab05fa0c9489c2305a09

[4] Marchionatti E, Kittl S, Sendi P, et al. Whole genome-based antimicrobial resistance, virulence, and phylogenetic characteristics of Trueperella pyogenes clinical isolates from humans and animals. Vet Microbiol. 2024. https://www.semanticscholar.org/paper/0b7ff32097a699285a721313a4b80a262958680f

[5] Wei Y, Wang B, Wu K, et al. Prevalence, Virulence Genes, Drug Resistance and Genetic Evolution of Trueperella pyogenes in Small Ruminants in Western China. Animals. 2024. https://www.semanticscholar.org/paper/2bae57a17c7f20f8886dce97d5075885263ba61d

[6] Yang M, Hu Y, Wang J, et al. Trueperella pyogenes promotes the synthesis and maturation of IL-1β in murine macrophages. Front Immunol. 2025. https://www.semanticscholar.org/paper/bfbd897b7976c0b1740e06ea175be6a93ee0dd21

[7] Kwiecień E, Stefańska I, Kizerwetter-Świda M, et al. Genetic diversity and virulence properties of caprine Trueperella pyogenes isolates. BMC Vet Res. 2024. https://www.semanticscholar.org/paper/b5527e380505b6796349a120f7cb38b35338476f

[8] Zheng Y, Yu Q, Han L, et al. Molecular Characterization of Resistance and Virulence Factors of Trueperella pyogenes Isolated from Clinical Bovine Mastitis Cases in China. Infect Drug Resist. 2024. https://www.semanticscholar.org/paper/44848d4ed3b917eca9f82d0bedbc8f30c2788b41

[9] Li D, Li H, Wang Z, et al. Time- and dose-dependent activation of the NLRP3 and MyD88/NF-κB pathways by Trueperella pyogenes membrane vesicles in bovine endometrial epithelial cells. Vet Res. 2025. https://www.semanticscholar.org/paper/2b6fb26eaf650f5f651fb20a2e4562f6af57d1d5

[10] Yamamoto S, Okumura S, Kobayashi R, et al. Bovine respiratory syncytial virus enhances the attachment of Trueperella pyogenes to cells. J Vet Med Sci. 2024. https://www.semanticscholar.org/paper/6b0e06eba670eb694ecb97e2bbcfb8783f6e97cb

[11] Nishi K, Gondaira S, Hirano Y, et al. Biofilm characterisation of Mycoplasma bovis co-cultured with Trueperella pyogenes. Vet Res. 2025. https://www.semanticscholar.org/paper/c1d23f1c9fa2b192678793dca227362a2b67e94b

[12] Szenci O, Jerzsele Á, Somogyi Z, et al. Determination of Minimum Inhibitory Concentrations of Selected Antibiotics Against Trueperella pyogenes Originated from Bovine Clinical Endometritis. Pathogens. 2025. https://www.semanticscholar.org/paper/ef37d447441bf6efe204bbc71560a1d2431d7560

[13] Kim Y, Ji MJ, Park J, et al. Case report: Omphalitis caused by Trueperella pyogenes infection in a Korean indigenous calf. Front Vet Sci. 2024. https://www.semanticscholar.org/paper/f6ba4044462ad299fa939fc5a586ed0479441434

[14] Mahaki ME, Sadeghian Chaleshtori S, Abdollahi M, et al. Granulomatous Omentitis in Multiple Sheep Associated With Trueperella pyogenes and Corynebacterium pseudotuberculosis: A Case Series. Vet Med Sci. 2025. https://www.semanticscholar.org/paper/e3690eadd4442620bcaf2dfee251d3bb89e831e2

[15] Magossi G, Gzyl KE, Holman D, et al. Genomic and metabolic characterization of Trueperella pyogenes isolated from domestic and wild animals. bioRxiv. 2024. https://www.semanticscholar.org/paper/6a0c356c4f71bf9c50bd6848c2737b8377f130f6

[16] Kizerwetter-Świda M, Kwiecień E, Stefańska I, et al. First Molecular Characterization of Trueperella pyogenes Isolated from a Rabbit Periodontal Abscess. Vet Sci. 2025. https://www.semanticscholar.org/paper/a2c25fbc8d51337ff3d65c350761e0110b43976b

[17] Ji MJ, Kim Y, Choi KS. Distribution of antibiotic resistance and virulence genes in Trueperella pyogenes isolated from Korean native cattle. Vet Microbiol. 2025. https://www.semanticscholar.org/paper/30f63ca984e580172717cdaf9948fd4578ecfc97

[18] Kwiecień E, Zając M, Bomba A, et al. Development of the multilocus sequence typing (MLST) scheme for molecular typing of Trueperella pyogenes. Vet Microbiol. 2025. https://www.semanticscholar.org/paper/fff00f734fb4fb45997e6130a5304cfe59658ba0

[19] Guo Y, Su H, Yu L, et al. PknB and STP as potential targets of luteolin in combating Trueperella pyogenes infections. Sci Rep. 2025. https://www.semanticscholar.org/paper/fdc7fbe445e5e75e05843aa602eea678c4edfe3e

[20] Bian H, Zhang S, Zhu Z, et al. Preparation and evaluation of genetically engineered recombinant subunit vaccines containing serine metalloprotease, anchor M domain-containing protein, and pyolysin against Trueperella pyogenes infection in a mouse model. Vaccine. 2025. https://www.semanticscholar.org/paper/b2722c493167b0cd0724e528ee6bee3785f96692

[21] Beikzadeh B. Immunoinformatics design of novel multi-epitope vaccine against Trueperella Pyogenes using collagen adhesion protein, fimbriae, and pyolysin. Arch Microbiol. 2024. https://www.semanticscholar.org/paper/3b943b9e26d075f4f1ef2b3fc8b9e1012cae352d

[22] Yang N, Li